Adams Brian — SEC Form 4 filings
SEC reporting owner CIK 1636994. 17 Form 4 filings on record with FilingPulse; latest filed 2026-09-04.
Transaction summary — filings shown
Covers all 17 filings on record, filed 2024-01-18 to 2026-09-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 18 legs across 13 filings — 103,707 shares, $1,171,822 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
- Largest priced transaction: sale of 3,025 shares @ $116.81 ($353,350) in Kymera Therapeutics, Inc., filed 2026-09-04.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | Chief Legal Officer | 3 | — | 3 legs · 6,371 sh · $744,297 | 4 |
| Relay Therapeutics, Inc. (RLAY) | Chief Legal Officer | 14 | — | 15 legs · 97,336 sh · $427,524 | 3 |
Form 4 filings — Adams Brian
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-04 | 4 | Kymera Therapeutics, Inc. (KYMR) | Sale (S): 1,209 @ $115.55 · Sale (S): 3,025 @ $116.81 · Sale (S): 2,137 @ $117.57 | EDGAR |
| 2026-03-04 | 4 | Kymera Therapeutics, Inc. (KYMR) | Grant/award (A): 4,125 @ $0 · Grant/award (A): 8,250 (derivative) @ $0 | EDGAR |
| 2025-09-03 | 4 | Kymera Therapeutics, Inc. (KYMR) | Grant/award (A): 52,500 @ $0 · Grant/award (A): 105,000 (derivative) @ $0 | EDGAR |
| 2025-07-30 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 1,637 @ $3.74 · Sale (S): 18,276 @ $3.68 | EDGAR |
| 2025-04-30 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 1,644 @ $3.17 · Sale (S): 12,943 @ $3 | EDGAR |
| 2025-03-31 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 298 @ $2.84 | EDGAR |
| 2025-01-30 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 33,688 @ $4.63 · Grant/award (A): 139,141 @ $0 · Sale (S): 20,791 @ $4.42 | EDGAR |
| 2025-01-14 | 4 | Relay Therapeutics, Inc. (RLAY) | Grant/award (A): 275,000 (derivative) @ $0 | EDGAR |
| 2024-12-31 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 299 @ $4.38 | EDGAR |
| 2024-10-30 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 1,632 @ $6.06 | EDGAR |
| 2024-10-01 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 295 @ $7.51 | EDGAR |
| 2024-07-31 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 1,638 @ $8.85 | EDGAR |
| 2024-07-01 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 295 @ $6.26 | EDGAR |
| 2024-04-29 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 1,623 @ $6.38 | EDGAR |
| 2024-03-29 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 348 @ $7.70 | EDGAR |
| 2024-01-31 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 1,929 @ $9.64 | EDGAR |
| 2024-01-18 | 4 | Relay Therapeutics, Inc. (RLAY) | Grant/award (A): 200,000 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1636994 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →